Evidence map›Paper›PMID 28096154›Full record

ArticleAntimicrobial agents and chemotherapy2017

Influence of

Zackery P Bulman, Neang S Ly, Justin R Lenhard, Patricia N Holden, Jürgen B Bulitta, Brian T Tsuji

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Frontiers in microbiology · 2021
    Article
  8. Review
  9. Inhibitory effects of 1,3-diaminopropane on the biofilm formation ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Zackery P BulmanLaboratory for Antimicrobial Pharmacodynamics, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
Neang S LyLaboratory for Antimicrobial Pharmacodynamics, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.ORCID 0000-0002-5571-0347
Justin R LenhardCalifornia Northstate University College of Pharmacy, Elk Grove, California, USA.
Patricia N HoldenLaboratory for Antimicrobial Pharmacodynamics, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.
Jürgen B BulittaCenter for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, Florida, USA.
Brian T TsujiLaboratory for Antimicrobial Pharmacodynamics, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA btsuji@buffalo.edu.
University at Buffalo, State University of New York · USCalifornia Northstate University · USUniversity of Florida · US

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative SuperbugsR01AI111990 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LI, JIAN, TSUJI, BRIAN · 2014 to 2018
$4.4M
NCATS NIH HHS UL1 TR001412NIAID NIH HHS R01 AI111990
6 · The paper itself

Abstract

The impact of quorum sensing on polymyxin and azithromycin pharmacodynamics was assessed in

Indexed as

Gene Expression Regulation, BacterialAnti-Bacterial AgentsAzithromycinBacterial ProteinsColony Count, MicrobialDose-Response Relationship, DrugDrug CombinationsDrug SynergismInhibitory Concentration 50Polymyxin BPseudomonas aeruginosaQuorum SensingTrans-ActivatorsAnti-Bacterial AgentsAzithromycinBacterial ProteinsDrug CombinationsLasR protein, Pseudomonas aeruginosaPolymyxin BRhlR protein, Pseudomonas aeruginosaTrans-Activatorsazithromycincolistinmechanism-based modelingP. aeruginosapharmacodynamicspolymyxin BpolymyxinsPseudomonas aeruginosaquorum sensing

Identifiers

PMID28096154
PMCPMC5365695
OpenAlexW2579754504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.